Cargando…

The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer

PURPOSE: Dose coverage is crucial for successful treatment in mono-brachytherapy. Since few and very high dose fractions are used, there is an important balance between dwell positioning outside the clinical target volume (CTV) and possible damage on adjacent normal tissue. The purpose of this study...

Descripción completa

Detalles Bibliográficos
Autores principales: Karlsson, Leif, Thunberg, Per, Johansson, Bengt, Persliden, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200186/
https://www.ncbi.nlm.nih.gov/pubmed/25337130
http://dx.doi.org/10.5114/jcb.2014.45586
_version_ 1782340031319375872
author Karlsson, Leif
Thunberg, Per
Johansson, Bengt
Persliden, Jan
author_facet Karlsson, Leif
Thunberg, Per
Johansson, Bengt
Persliden, Jan
author_sort Karlsson, Leif
collection PubMed
description PURPOSE: Dose coverage is crucial for successful treatment in mono-brachytherapy. Since few and very high dose fractions are used, there is an important balance between dwell positioning outside the clinical target volume (CTV) and possible damage on adjacent normal tissue. The purpose of this study was to evaluate the possibility of having dwell positions close to the CTV surface, while maintaining an acceptable dose distribution, and to investigate the robustness in terms of known geometrical uncertainties of the implant. MATERIAL AND METHODS: This study included 37 patients who had received brachytherapy for prostate cancer as a monotherapy with the following schedules: 2 × 14 Gy or 3 × 11 Gy, each fraction separated by two weeks. The source dwell positions were activated 5 mm outside CTV. New optimizations were simulated for dwell positions at 3, 2, 1, and 0 mm. Inverse and graphical optimization were applied according to the relative dose constraints: V(100 CTV) ≥ 97%, D(max, urethra) ≤ 110%, and D(10 rectal mucosa) ≤ 65%. The V(100, normal tissue) outside CTV was used to evaluate dose variations caused by different dwell positions. Prostate geometries and dose distributions for the different dwell positions outside the CTV were used to investigate the impact on the CTV dose distribution due to geometrical uncertainties. RESULTS: Both V(100, CTV), and V(100, normal tissue) decreased, 98.6% to 92.2%, and 17 cm(3) to 9.0 cm(3), for dwell activation from 5 mm to 0 mm. The evaluation of both simulated longitudinal geometrical uncertainties and different source dwell activations implied that V(100, CTV) ranged from 98.6% to 86.3%. CONCLUSIONS: It is possible to reduce the V(100, normal tissue) by decreasing the source dwell positions outside the CTV from 5 to 3 mm, while maintaining dose constraints. In combination with the estimated geometrical uncertainties, however, the source dwell positions need to be 5 mm from the surface in order to maintain a robust implant.
format Online
Article
Text
id pubmed-4200186
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-42001862014-10-21 The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer Karlsson, Leif Thunberg, Per Johansson, Bengt Persliden, Jan J Contemp Brachytherapy Original Paper PURPOSE: Dose coverage is crucial for successful treatment in mono-brachytherapy. Since few and very high dose fractions are used, there is an important balance between dwell positioning outside the clinical target volume (CTV) and possible damage on adjacent normal tissue. The purpose of this study was to evaluate the possibility of having dwell positions close to the CTV surface, while maintaining an acceptable dose distribution, and to investigate the robustness in terms of known geometrical uncertainties of the implant. MATERIAL AND METHODS: This study included 37 patients who had received brachytherapy for prostate cancer as a monotherapy with the following schedules: 2 × 14 Gy or 3 × 11 Gy, each fraction separated by two weeks. The source dwell positions were activated 5 mm outside CTV. New optimizations were simulated for dwell positions at 3, 2, 1, and 0 mm. Inverse and graphical optimization were applied according to the relative dose constraints: V(100 CTV) ≥ 97%, D(max, urethra) ≤ 110%, and D(10 rectal mucosa) ≤ 65%. The V(100, normal tissue) outside CTV was used to evaluate dose variations caused by different dwell positions. Prostate geometries and dose distributions for the different dwell positions outside the CTV were used to investigate the impact on the CTV dose distribution due to geometrical uncertainties. RESULTS: Both V(100, CTV), and V(100, normal tissue) decreased, 98.6% to 92.2%, and 17 cm(3) to 9.0 cm(3), for dwell activation from 5 mm to 0 mm. The evaluation of both simulated longitudinal geometrical uncertainties and different source dwell activations implied that V(100, CTV) ranged from 98.6% to 86.3%. CONCLUSIONS: It is possible to reduce the V(100, normal tissue) by decreasing the source dwell positions outside the CTV from 5 to 3 mm, while maintaining dose constraints. In combination with the estimated geometrical uncertainties, however, the source dwell positions need to be 5 mm from the surface in order to maintain a robust implant. Termedia Publishing House 2014-09-23 2014-10 /pmc/articles/PMC4200186/ /pubmed/25337130 http://dx.doi.org/10.5114/jcb.2014.45586 Text en Copyright © 2014 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Karlsson, Leif
Thunberg, Per
Johansson, Bengt
Persliden, Jan
The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title_full The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title_fullStr The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title_full_unstemmed The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title_short The impact of activating source dwell positions outside the CTV on the dose to treated normal tissue volumes in TRUS guided 3D conformal interstitial HDR brachytherapy of prostate cancer
title_sort impact of activating source dwell positions outside the ctv on the dose to treated normal tissue volumes in trus guided 3d conformal interstitial hdr brachytherapy of prostate cancer
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200186/
https://www.ncbi.nlm.nih.gov/pubmed/25337130
http://dx.doi.org/10.5114/jcb.2014.45586
work_keys_str_mv AT karlssonleif theimpactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT thunbergper theimpactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT johanssonbengt theimpactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT perslidenjan theimpactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT karlssonleif impactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT thunbergper impactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT johanssonbengt impactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer
AT perslidenjan impactofactivatingsourcedwellpositionsoutsidethectvonthedosetotreatednormaltissuevolumesintrusguided3dconformalinterstitialhdrbrachytherapyofprostatecancer